STATE OF THE STATE: New Jersey
How Green Is the Garden State?
If you live in New Jersey and you are in need of some medical marijuana, good news. On January 11th, 2010 The New Jersey Compassionate Use Medical Marijuana Act was passed by the state legislature and on January 18th, 2010 it was signed into law by then governor John Corzine.
The Act approves medical marijuana for use in treating over a dozen different ailments and contains provisions for expanding the list. Legalization of marijuana for recreational use is currently being hotly debated in the state legislature and the outcome is unsure at this time.
So that’s the good news; the bad news is that New Jersey medical marijuana prices are among the highest in the nation averaging about thirty-seven percent more per ounce than other states. The five dispensaries in the state charge an average of $489 per ounce, while the average price at dispensaries in Arizona, New Mexico, Vermont, Maine and Rhode Island is around $311 per ounce.
These prices are in part caused by the fact that New Jersey’s medical marijuana regulations are significantly more cumbersome than the regulations in many other states.
Here are the highlights:
- There are fewer than four hundred physicians who have registered to recommend medical marijuana to patients.
- New Jersey doctors need to specify in their “recommendation,” as writing prescriptions is not allowed by federal law, the amount of marijuana that a patient will require. However, there is a maximum limit of 2 ounces of usable cannabis per 30-day period. This is too restrictive.
- These recommendations do not name a strain, only recommend a dosage.
- New Jersey regulations do not specify specific strains that may be cultivated instead classifying cannabis plants as either “low”, “medium”, or “high” dose plants. The maximum concentration of THC, the psychoactive component in cannabis, is ten percent.
- All patients participating in the program must have their conditions reassessed every 90 days.
- Patients are required to have a medical marijuana recommendation (not a prescription) from a certified physician, a government-issued ID, and proof of New Jersey residency to register. New Jersey has about fifteen thousand registered patients.
- Approved methods of use: smoke, vape, tincture, topical – and highly restricted use of edibles. This form is only allowed for children with approved conditions.
- The Act mandates the establishment of six non-profit “alternative treatment centers”. That’s not many for a state with over nine million residents.
- Additional centers may be for-profit but so far none have been created.
- Home delivery is prohibited which means some patients will have a commute to obtain their cannabis.
- Most states with legalized medical marijuana laws allow patients to grow a limited number of their own plants but not New Jersey.
The new administration in NJ has pledged to quickly reform the regulatory framework which was deliberately designed by the Christie administration to suppress the industry. The legislature and the Department of Health have already begun to move toward the de-regulation, so the outlook for NJ patients is brightening up. We will wait and see.
A marketing and publishing professional and the Director of Publicity at GB Sciences, Liz Bianco monitors media activity and the “State of the States” on cannabis in America.
DISCLAIMER REGARDING SITE CONTENT AND RELATED MATERIALS
Please read these terms and conditions fully and carefully. If you do not agree to be bound to each and every term and condition set forth herein, please exit the Site and do not access, read or otherwise use information provided herein.
The blog provides only general information and discussion about medicine, health and related subjects. Any views or opinions represented in this blog are personal and belong solely to the specific author and do not represent those of people, academic, hospital, practice or other institutions or organizations that the author may or may not be associated with in professional or personal capacity, and do not represent the views or opinions of GB Sciences, Inc., unless explicitly stated.
The words and other content provided in this blog, and in any linked materials, are not intended and should not be construed as medical advice. Nothing contained in the Site is intended to establish a physician-patient relationship, to replace the services of a trained physician or health care professional, or otherwise to be a substitute for professional medical advice, diagnosis, or treatment. If the reader or any other person has a medical concern, he or she should consult with an appropriately-licensed physician or other health care worker. The information is provided by the specific author and the author makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the information, products, services, or related graphics contained in the blog for any purpose. Any reliance placed on such information is therefore strictly at the reader’s own risk.
This blog may contain statements that could be construed to relate to future results or events. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the specific author’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the specific author’s control. The specific author’s beliefs are not the beliefs of GB Sciences, Inc., and do not represent the views or opinions of GB Sciences, Inc., unless explicitly stated.
It is possible that the actual results and financial condition of GB Sciences, Inc., may differ, possibly materially, from the anticipated results and financial conditions suggested in these forward-looking statements by the blog author. Information concerning the GB Sciences, Inc., and its business, including factors that potentially could materially affect GB Sciences, Inc., are contained in the company’s filings with the Securities and Exchange Commission, available at www.sec.gov. Any forward-looking statements included in this blog are made only as of the date of this blog, and neither the specific blog author nor GB Sciences, Inc., undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which they may hereafter become aware.
Through this website and blog you are able to link to other websites that are not under the control of the blog author or GB Sciences, Inc. The blog author and GB Sciences, Inc., have no control over the nature, content and availability of those sites. The inclusion of any links does not imply a recommendation or endorsement of the views and opinions expressed within them.
Content made available at the Site is provided on an “as is” and “as available” basis without warranties of any kind, either express or implied. Under no circumstances, as a result of your use of the Site, will the specific author or GB Sciences, Inc., be liable to you or to any other person for any direct, indirect, incidental, consequential, special, exemplary or other damages under any legal theory, including, without limitation, tort, contract, strict liability or otherwise, even if advised of the possibility of such damages.
By accessing the Site and/or reading its content, you acknowledge and agree that you have read and understand these terms and conditions, that the provisions, disclosures and disclaimers set forth herein are fair and reasonable, and that your agreement to follow and be bound by these terms and conditions is voluntary and is not the result of fraud, duress or undue influence exercised upon you by any person or entity.